Manejo del dolor Osteoarticular en Pacientes Caninos con un Extracto Activo de CBD (Monografía)
Share
Date
2024-06-25
Authors
Director(s)
Publisher
Universidad Antonio Nariño
Campus
Faculty
Program
Degree obtained
Document type
COAR type
http://purl.org/coar/resource_type/c_46ec
Citation
Bibliographic Managers
Document Viewer
Select a file to preview:
item.page.resume
Abstract
Degenerative joint disease (DJD) in dogs, a concern both emotionally and
clinically for owners and veterinarians, has sparked growing interest in exploring more
effective therapeutic options. This study focused on investigating the therapeutic
potential of cannabidiol (CBD) for pain management in dogs with DJD. Through a
methodology that included the collection and classification of information from
secondary sources, studies published between 2010 and 2022 addressing the
pharmacokinetics and dynamics of CBD in this population were selected. The results
revealed that CBD interacts with receptors of the endocannabinoid system (ECS),
reducing the perception of pain and inflammation in joints affected by DJD.
Additionally, it was observed that CBD preserves cartilage integrity and provides
sustained pain relief, with therapeutic advantages over conventional analgesic therapy
due to its safety profile and comprehensive ability to address underlying DJD
symptoms.